Skip to main content
FinSpry Logo
FinSpry
XBIO logo
XBIO
(NASDAQ)
Xenetic Biosciences, Inc.
$2.93-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Xenetic Biosciences (XBIO) Stock Price & Financial Analysis

Xenetic Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.88 - $2.98
52-Week High$13.93
52-Week Low$1.90
Open$2.88
Volume2.85K
Average Volume (3M)15.60K
Market Cap4.99M
Shares Outstanding1.70M
Price to Sales (P/S)1.74
Price to Book (P/B)0.70
EV/EBITDA0.96
Revenue (TTM)2.98M
Net Income (TTM)-2.68M
Free Cash Flow (TTM)-2.29M
EPS (TTM)$-1.55
Profit Margin-90.07%
Operating Margin-95.23%
Return on Equity (ROE)-36.25%
Debt to Equity0.00
50-Day MA$2.98
200-Day MA$2.93
52-Week Change1.29%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Xenetic Biosciences

What is the current stock price for XBIO?

As of the latest trading session, XBIO stock trades at $2.90. The 52-week range is $1.90–$13.93, with a day range of $2.88–$2.98.

What is the P/E ratio for XBIO?

The P/E ratio (Price-to-Earnings) for XBIO is shown in the Key Statistics section. This valuation metric helps compare Xenetic Biosciences, Inc. to industry peers.

Does XBIO pay dividends?

Xenetic Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XBIO?

Analyst ratings and recommendations for XBIO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of XBIO?

Xenetic Biosciences's market capitalization is $4.9M, classifying it as a micro-cap company. Xenetic Biosciences operates in the Healthcare sector within the Biotechnology industry.